Given that multiple immune-related signaling pathways were significantly associated with the DNAJC3 high-expression group (Fig. 4A), we further explored the relationship between DNAJC3 and the glioma immune microenvironment using various algorithms. The gene discussed is DNAJC3; the disease is central nervous system cancer.